0I3Q Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Corcept Therapeutics Inc

Watchlist Manager

Watchlist

Price: 60.148 USD 0.87% Market Closed

Market Cap: $6.3B

	Corcept Therapeutics Inc LSE:0I3Q	US
	China Resources Beer Holdings Co Ltd F:CHK0	HK
R	Reach PLC SWB:MRR	UK
	Huaneng Power International Inc F:HUP	CN
	Fanuc Corp OTC:FANUY	JP
	New Jersey Resources Corp F:NJ1	US
	Northam Platinum Holdings Ltd F:7JR	ZA
	Citius Pharmaceuticals Inc NASDAQ:CTXR	US
H	Hewlett Packard Enterprise Co F:2HP	US
	News Corp NASDAQ:NWSA	US
	Lintec Corp OTC:LNTEF	JP
G	GEN Restaurant Group Inc NASDAQ:GENK	US
G	Grand Canyon Education Inc SWB:GKD	US
A	Assa Abloy AB SWB:ALZC	SE
C	Citigroup Inc LSE:0R01	US
B	Bic Camera Inc F:1U3	JP

Profitability Summary

Corcept Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

98%

Strong 3Y Average Gross Margin

98%

Declining Gross Margin

99% > 98%

Negative Operating Margin

-1%

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

24% > -1%

Low Net Margin

Sustainable 3Y Average Net Margin

19%

Declining Net Margin

23% > 6%

Exceptional Free Cash Flow Margin

16%

Strong 3Y Average Free Cash Flow Margin

25%

Declining Free Cash Flow Margin

27% > 16%

Low ROE

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

36%

Declining ROIC

69% > -7%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.